Table 2.

Antimicrobial activity assessment of compounds 7–17 using agar diffusion technique.

Compound	Inhibition zones diameter (mm)
	B. mycoides	E. coli	C. albicans
7	36 ± 1.25	30 ± 0.74	37 ± 1.20
8	37 ± 0.23	29 ± 0.44	38 ± 0.67
9	41 ± 0.0	37 ± 0.74	41 ± 0.21
10	24 ± 0.87	22 ± 0.39	21 ± 0.32
11	31 ± 0.52	27 ± 0.58	32 ± 0.17
13	16 ± 0.41	18 ± 1.84	18 ± 0.66
14	15 ± 0.25	17 ± 0.81	17 ± 0.27
15	23 ± 0.35	24 ± 0.68	24 ± 1.22
16	16 ± 0.97	16 ± 0.35	16 ± 0.95
17	18 ± 0.0	16 ± 0.54	15 ± 0.42
DMSO (control)	0	0	0
Colstin 10 mcg	0	0	0
Tobramycin 10 mcg	10 ± 0.31	13 ± 0.22	12 ± 0.61
Gentamicin 10 mcg	11 ± 0.43	12 ± 0.18	12 ± 0.89
Ampicillin 10 mcg	12 ± 0.93	20 ± 1.05	14 ± 0.25
Erythromycin 15 mcg	17 ± 0.15	29 ± 2.13	25 ± 0.00

Significant values are in italics.

200 μL of dissolved compounds (10 mg/mL) in DMSO were applied to 15 mm holes prepared in the inoculated agar plates. Culture plates were incubated overnight at 37 °C.